The influence of pharmacogenetics on fatty liver disease in the Wistar and Kyoto rats: A combined transcriptomic and metabonomic study

Journal of Proteome Research

Volumn 6, Issue 1, 2007, Pages 54-61

  Griffin, Julian L ^a   Scott, James ^b   Nicholson, Jeremy K ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Metabolic profiling; Metabolomics; Nonalcoholic steatohepatisis; Pattern recognition

Indexed keywords

APOLIPOPROTEIN B; BETAINE; CHOLINE; GLUCOSE; GLYCOGEN; OROTIC ACID; PHOSPHORYLCHOLINE; POLYUNSATURATED FATTY ACID; TRIMETHYLAMINE OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FATTY LIVER; GENE EXPRESSION PROFILING; HOMEOSTASIS; MALE; METABOLOMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOREGULATION; OXIDATIVE STRESS; PH; PHARMACOGENETICS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; TRANSCRIPTOMICS;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION PROFILING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PATTERN RECOGNITION, AUTOMATED; PHARMACOGENETICS; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; RATS; RATS, INBRED WKY; RATS, WISTAR; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 33846625887     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0601640     Document Type: Article

References (20)

1. Matteoni, C. A.; Younossi, Z. M.; Gramlich, T.; Boparai, N.; Liu, Y. C.; McCullough, A. J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116, 1413-1419.
2. Younossi, Z. M.; Diehl, A. M.; Ong, J. P. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002, 35, 746-752.
3. Ludwig, J.; Viggiano, T. R.; McGill, D. B.; Oh, B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc. 1980, 55, 434-438.
4. Chitturi, S.; Farrell, G. C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin. Liver Dis. 2001, 21, 27-41.
5. Marchetti, M.; Puddu, P.; Caldarera, C. M. Metabolic aspects of "orotic acid fatty liver" Nucleotide control mechanisms of lipid metabolism. Biochem. J. 1964, 92, 46-51.
6. Roheim, P. S.; Switzer, S.; Girard, A.; Eder, H. A. The mechanism of inhibition of lipoprotein synthesis by orotic acid. Biochem. Biophys. Res. Commun. 1965, 20, 416-21.
7. Griffin, J. L.; Bonney, S. A.; Mann, C.; Hebbachi, A. M.; Gibbons, G. F.; Nicholson, J. K.; Shoulders, C. C.; Scott, J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics 2004, 17, 140-9.
8. Griffin, J. L.; Williams, H. J.; Sang, E.; Clarke, K.; Rae, C.; Nicholson, J. K. Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal. Biochem. 2001, 293, 16-21.
9. Bollard, M. E.; Garrod, S.; Holmes, E.; Lindon, J. C.; Humpfer, E.; Spraul, M.; Nicholson, J. K. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn. Reson. Med. 2000, 44, 201-7.
10. Beckwith-Hall, B. M.; Nicholson, J. K.; Nicholls, A. W.; Foxall, P. J.; Lindon, J. C.; Connor, S. C.; Abdi, M.; Connelly, J.; Holmes, E. Nuclear magnetic resonance spectroscopic and principal components anlysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 1998, 11, 260-72.
11. Marchesini, G.; Brizi, M.; Bianchi, G.; Tomassetti, S.; Bugianesi, E.; Lenzi, M.; McCullough, A. J.; Natale, S.; Forlani, G.; Melchionda, N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50, 1844-1850.
12. Sanyal, A. J.; Campbell-Sargent, C.; Mirshahi, F.; Rizzo, W. B.; Contos, M. J.; Sterling, R. K.; Luketic, V. A.; Shiftman, M. L.; Clore, J. N. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120, 1183-1192.
13. Makino, Y.; Mimori, T.; Koike, C.; Kanemaki, M.; Kurokawa, Y.; Inoue, S.; Kishimoto, T.; Tamura, T. TIP49, homologous to the bacterial DNA helicase RuvB, acts as an autoantigen in human. Biochem. Biophys. Res. Commun. 1998, 245 (3), 819-23.
14. Watano, K.; Iwabuchi, K.; Fujii, S.; Ishimori, N.; Mitsuhashi, S.; Ato, M.; Kitabatake, A.; Onoe, K. Allograft inflammatory factor-1 augments production of interleukin-6, -10 and -12 by a mouse macrophage line. Immunology 2001, 104 (3), 307-16.
15. Yarov-Yarovoy, V.; Paucek, P.; Jaburek, M.; Garlid, K. D. The nucleotide regulatory sites on the mitochondrial KATP channel face the cytosol. Biochim. Biophys. Acta. 1997, 1321 (2), 128-36.
16. Acton, S. L.; Scherer, P. E.; Lodish, H. F.; Krieger, M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 1994, 269 (33), 21003-9.
17. Hytiroglou, P.; Choi, S. W.; Theise, N. D.; Chaudhary, N.; Worman, H. J.; Thung, S. N. The expression of nuclear lamins in human liver: an immunohistochemical study. Hum. Pathol. 1993, 24 (2), 169-72.
18. Urade, Y.; Hayaishi, O. Prostaglandin D synthase: structure and function. Vitam. Horm. 2000, 50, 89-120.
19. Chan, C. F.; Yau, T. O.; Jin, D. Y.; Wong, C. M.; Fan, S. T.; Ng, I. O. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin. Cancer Res. 2004, 10 (12 Pt 1), 4140-9.
20. Atlashkin, V.; Kreykenbohm, V.; Eskelinen, E. L.; Wenzel, D.; Fayyazi, A.; Fischer von Mollard, G. Deletion of the SNARE vti1b in mice results in the loss of a single SNARE partner, syntaxin 8. Mol. Cell Biol. 2003, 23 (15), 5198-207.